A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)

Name: A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
License: Public Domain

Merck Sharp & Dohme LLC

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

small cell lung cancer extensive stage

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 136346
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.